KUMAR, V.; PANDA, B. K. CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 10, n. 3, p. 363–366, 2017. DOI: 10.22159/ajpcr.2017.v10i3.16308. Disponível em: https://journals.innovareacademics.in/index.php/ajpcr/article/view/16308. Acesso em: 4 nov. 2024.